JFG
CAPR icon

Jefferies Financial Group’s Capricor Therapeutics CAPR Stock Holding History

Jefferies Financial Group’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55M Buy
105,755
+1,394
+1% +$42.3K 0.02% 607
2026
Q1 		$3.17M Buy
+104,361
New +$2.78M 0.02% 457
2024
Q2 		– Sell
-10,600
Closed -$72K – 1451
2024
Q1 		$72K Buy
+10,600
New +$51.3K ﹤0.01% 1471

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jefferies Financial Group's CAPR Position: Q2 2026 in Review

Jefferies Financial Group increased its Capricor Therapeutics (CAPR) stake by 1.3% in Q2 2026, buying an estimated $42.3K and bringing the position to 105,755 shares worth $2.55M. The position accounts for 0.02% of the portfolio, ranked #607.

Jefferies Financial Group first reported a position in CAPR in Q1 2024 and has held it in 3 quarters since. The position peaked at $3.17M in Q1 2026. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Jefferies Financial Group held 105,755 shares of Capricor Therapeutics worth $2.55M as of Q2 2026.
  • Jefferies Financial Group bought 1,394 Capricor Therapeutics shares in Q2 2026, an estimated $42.3K.
  • Capricor Therapeutics made up 0.02% of Jefferies Financial Group's portfolio in Q2 2026, its #607 holding.
  • Jefferies Financial Group first reported a position in Capricor Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • Jefferies Financial Group's Capricor Therapeutics position peaked at $3.17M in Q1 2026.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.